GSK plc (GSK:NYSE)
$58.07 -1.47 (-2.47%)
Analysed GSK plc (GSK:NYSE) News Sources
GSK’s bepirovirsen accepted for regulatory review in Japan as a potential first-in-class treatment for chronic hepatitis B
Pharmabiz
GSK pays $950m for a pulmonary hypertension drug designed to avoid the bleeding risk that limits rival treatments
Yahoo Finance UK
GSK to acquire clinical-stage biopharma company, 35Pharma Inc for $950 million
Pharmabiz
GSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play
Benzinga on MSN
GSK moves towards clearance of two new drugs in China and Japan
London South East
GSK study flags low Shingles awareness among older Indians despite rising risk
Moneycontrol
GSK buys Canadian biopharmaceutical firm 35Pharma for USD950 million
London South East
GSK calls for more conversations on shingles prevention in adults
The Hindu BusinessLine
GSK Strikes $1 Billion China RNA Deal
Yahoo Finance UK
GSK to buy 35Pharma for $950 million in CEO Miel's second major deal
Reuters on MSN
What is the current price of GSK plc (GSK:NYSE)?
The current price of GSK plc (GSK:NYSE) is $58.07.
GSK plc (GSK:NYSE) absolute price change since previous trading day?
The absolute price change of GSK plc (GSK:NYSE) since the previous trading day is $-1.47.
GSK plc (GSK:NYSE) percentage price change since previous trading day?
The percentage price change of GSK plc (GSK:NYSE) since the previous trading day is -2.47%.
What is This Week's average sentiment score for GSK plc (GSK:NYSE)?
This Week's average sentiment score for GSK plc (GSK:NYSE) is 76 out of 100.
What is This Week's average sentiment for GSK plc (GSK:NYSE)?
This Week's sentiment for GSK plc (GSK:NYSE) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.